Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment
- PMID: 28860758
- PMCID: PMC5571850
- DOI: 10.2147/IJN.S132162
Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment
Abstract
Superparamagnetic iron oxide nanoparticles (SPION) may be used for local tumor treatment by coupling them to a drug and accumulating them locally with magnetic field traps, that is, a combination of permanent magnets and coils. Thereafter, an alternating magnetic field generates heat which may be used to release the thermosensitively bound drug and for hyperthermia. Until today, only superficial tumors can be treated with this method. Our aim was to transfer this method into an endoscopic setting to also reach the majority of tumors located inside the body. To find the ideal endoscopic magnetic field trap, which accumulates the most SPION, we first developed a biophysical model considering anatomical as well as physical conditions. Entities of choice were esophageal and prostate cancer. The magnetic susceptibilities of different porcine and rat tissues were measured with a superconducting quantum interference device. All tissues showed diamagnetic behavior. The evaluation of clinical data (computed tomography scan, endosonography, surgical reports, pathological evaluation) of patients gave insight into the topographical relationship between the tumor and its surroundings. Both were used to establish the biophysical model of the tumors and their surroundings, closely mirroring the clinical situation, in which we could virtually design, place and evaluate different electromagnetic coil configurations to find optimized magnetic field traps for each tumor entity. By simulation, we could show that the efficiency of the magnetic field traps can be enhanced by 38-fold for prostate and 8-fold for esophageal cancer. Therefore, our approach of endoscopic targeting is an improvement of the magnetic drug-targeting setups for SPION tumor therapy as it holds the possibility of reaching tumors inside the body in a minimal-invasive way. Future animal experiments must prove these findings in vivo.
Keywords: SPION; drug targeting; esophageal cancer; prostate cancer; simulation.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- Häfeli UO, Chastellain M. Magnetic nanoparticles as drug carriers. In: Torchilin VP, editor. Nanoparticles as Drug Carriers. London: Imperial College Press; 2006.
-
- Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11(11):2319–2331. - PubMed
-
- Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh PK. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm. 2000;202(1–2):1–10. - PubMed
-
- Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab. 2002;22(8):899–907. - PubMed
-
- Jordan A, Maier-Hauff K, Wust P, Rau B, Johannsen M. Thermotherapie mit Nanopartikeln. Onkologie. 2007;13:894–902.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
